title: Evaluation of the profibrinolytic properties of a bispecific antibody-based inhibitor against human and mouse thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1.
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
authors.forename: T
authors.initials: T
authors.lastname: Wyseure
authors.forename: A
authors.initials: A
authors.lastname: Gils
authors.forename: P J
authors.initials: PJ
authors.lastname: Declerck
mesh_terms: D000818:Animals; D018033:Antibodies, Bispecific / Q000494:pharmacology*; D025901:Carboxypeptidase B2 / Q000378:metabolism*; D019446:Endotoxemia / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D020128:Inhibitory Concentration 50; D051379:Mice; D017395:Plasminogen Activator Inhibitor 1 / Q000378:metabolism*; D051381:Rats; D013916:Thrombelastography; D015912:Thrombolytic Therapy
chemical_list: D018033:Antibodies, Bispecific; D005343:Fibrinolytic Agents; D017395:Plasminogen Activator Inhibitor 1; D025901:Carboxypeptidase B2